Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEMBROSARC: MK3475 and Metronomic Cyclophosphamide in Advanced Sarcomas
NCT02406781Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Jun 2015
- Primary completion
- Nov 2020
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in sarcoma, sponsored by Institut Bergonié. Started Jun 2015; status: completed.
02
Drugs
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT02406781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406781.